Company profile: Massive Bio
1.1 - Company Overview
Company description
- Provider of an AI-powered oncology platform that connects cancer patients to clinical trials and enables pharma to access patients. Offers SYNERGY-AI clinical trial matching, AskFiona and DrArturo AI chatbots, telehealth consultations, genomics analysis for personalized treatment, and concierge services to help patients navigate care and trial options.
Products and services
- SYNERGY-AI Clinical Trial Matching Solution: An automation-enabled system that matches cancer patients with clinical trials using data extraction to streamline matching workflows and expedite trial identification
- Genomics Services: A genomics-based service that analyzes and interprets genetic data to inform personalized cancer treatment plans for oncology patients
- AskFiona AI: A chatbot-based AI that assists patients in finding clinical trials and understanding their options for cancer treatment
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Massive Bio
Insitro
HQ: United States
Website
- Description: Provider of an ML-driven drug discovery platform integrating in vitro cellular and clinical data; therapeutic programs in metabolism, oncology, and neuroscience; machine learning for disease redefinition and intervention identification; aggregation of clinical and phenotypic data; automated labs generating multimodal phenotypic cellular data; and pipelines for in-house and partnered programs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Insitro company profile →
Roam Analytics
HQ: United States
Website
- Description: Provider of a proprietary artificial intelligence platform for healthcare that transforms patient and physician pathway analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Roam Analytics company profile →
Nomic Bio
HQ: Canada
Website
- Description: Provider of a proteomic technology platform leveraging DNA nanotechnology to understand, detect, and treat diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nomic Bio company profile →
Ampersand Biomedicines
HQ: United States
Website
- Description: Provider of programmable medicines and platforms that precisely target disease sites, including AND-Body Therapeutics for disease-specific precision and modification; the AND-Platform, a computational and experimental system enabled by a proprietary Address Map; the Opportunity Atlas for identifying localized targets; and enhanced biologic generation via AbCheck’s antibody discovery technologies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ampersand Biomedicines company profile →
Clara Health
HQ: United States
Website
- Description: Provider of a software platform that streamlines clinical trial participation, offering patient trial matching based on health information and preferences, support before, during, and after studies (including travel and accommodations), tools for researchers to publicize studies, identity verification for participants and researchers, and online payments processing for incentives and services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clara Health company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Massive Bio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Massive Bio
2.2 - Growth funds investing in similar companies to Massive Bio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Massive Bio
4.2 - Public trading comparable groups for Massive Bio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →